Crewe Advisors’s Immunogen Inc IMGN Stock Holding History

Crewe Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-5	Closed	-$149	–	1032
2023 Q4	$149	Sell	5 -3	-38%	-$60	﹤0.01%	382
2023 Q3	$127	Buy	8 +1	+14%	+$17	﹤0.01%	515
2023 Q2	$133	Buy	+7	New	+$83	﹤0.01%	799

Other funds holding IMGN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Crewe Advisors's IMGN Position: Q1 2024 in Review

Crewe Advisors sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 5 shares — an estimated $149 sold.

Crewe Advisors first reported a position in IMGN in Q2 2023 and held it in 3 quarters. The position peaked at $149 in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

Crewe Advisors reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
Crewe Advisors sold 5 Immunogen Inc shares in Q1 2024, an estimated $149.
Crewe Advisors first reported a position in Immunogen Inc in Q2 2023 and held it in 3 quarters.
Crewe Advisors's Immunogen Inc position peaked at $149 in Q4 2023.
3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Crewe Advisors's 13F filing for Q1 2024, filed 14 May 2024.